Showing results (91-100 of 219) with videos related to

Sort By:
Pageof 22
Clinical Drug Investigation|March 29, 2008
Cost effectiveness of fluticasone and budesonide in patients with moderate asthmaK O Steinmetz, T Volmer, M Trautmann, et al.
Journal of Clinical Microbiology|March 1, 1995
Molecular epidemiology of Candida isolates from AIDS patients showing different fluconazole resistance profilesA Lischewski, M Ruhnke, I Tennagen, et al.
The Journal of Hospital Infection|January 9, 1998
Bacterial colonization and endotoxin contamination of intravenous infusion fluidsM Trautmann, B Zauser, H Wiedeck, et al.
Agents and Actions|July 1, 1991
Release of 15-hydroxy-5,8,11,13-eicosatetraenoic acid and cysteinyl-leukotrienes in carrageenin-induced inflammation: effect of non-steroidal anti-inflammatory drugsB M Peskar, M Trautmann, P Nowak, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1983
Netilmicin in human CSF after parenteral administration in patients with slightly and severely impaired blood CSF barrierO Brückner, M Trautmann, D Kolodziejczyk, et al.
European Journal of Clinical Microbiology|June 1, 1986
Serum bactericidal activity of two newer quinolones against Salmonella typhi compared with standard therapeutic regimensM Trautmann, B Krause, D Birnbaum, et al.
Infection|September 1, 1989
Comparative efficacy of ciprofloxacin, azlocillin, imipenem/cilastatin and tobramycin in a model of experimental septicemia due to Pseudomonas aeruginosa in neutropenic miceE Ulrich, M Trautmann, B Krause, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
Ciprofloxacin: a comparative evaluation of its bactericidal activity in human serum against four enterobacterial speciesD Weiss, M Trautmann, J Wagner, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1995
Effects of MICs and sub-MICs of antibiotics on production of capsular polysaccharide of Klebsiella pneumoniaeT K Held, C Adamczik, M Trautmann, et al.
European Journal of Medical Research|February 6, 2002
Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023)Claus Baumgarten, R Geldszus, U Behre, et al.
Pageof 22